Clinical trial breadth Well-established regional research provider with over twenty years of experience across multiple therapeutic areas including urology, sexual health, obstetrics/gynecology, cardiology, neurology, psychiatry, internal medicine, family medicine and cancer research, presenting cross-sell opportunities into diverse sponsor pipelines.

Mid-market scale Small to mid-sized organization (11-50 employees) with modest revenue, suggesting agility for sponsor-sponsored trials, faster decision cycles, and potential for long-term, multi-study partnerships with mid-tier sponsors looking for dedicated CRO-like capabilities.

regional footprint Location in Aventura, Florida positions the firm to capitalize on Southeast U.S. trial sites, access to local patient populations, and potential co-investment opportunities with nearby healthcare networks and academic affiliates.

digital footprint Existing website and tech stack (WordPress, MySQL, Google Analytics) indicate digital marketing capabilities; potential for optimized lead capture, CRM integration, and targeted campaigns to attract sponsors seeking niche regional sites.

recent expansion signals Notable activity around launching a low testosterone study in 2013 demonstrates ongoing trial initiation capacity and expertise in endocrinology/men’s health sectors, suggesting potential fit for related therapeutic areas and early-phase to Phase II opportunities.